CAPTRUST Financial Advisors
KYNB

CAPTRUST Financial Advisors’s Kyntra Bio KYNB Stock Holding History

CAPTRUST Financial Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-618
Closed -$13.7K – 2329
2023
Q4 		$13.7K Sell
618
-41
-6% -$618 ﹤0.01% 2629
2023
Q3 		$14.2K Buy
+659
New +$25.9K ﹤0.01% 2532
2023
Q2 		– Sell
-408
Closed -$190K – 2554
2023
Q1 		$190K Buy
+408
New +$216K ﹤0.01% 2064
2022
Q2 		– Sell
-17
Closed -$5K – 4988
2022
Q1 		$5K Sell
17
-37
-69% -$12.9K ﹤0.01% 4148
2021
Q4 		$19K Buy
54
+1
+2% +$311 ﹤0.01% 3309
2021
Q3 		$13K Buy
53
+20
+61% +$7.09K ﹤0.01% 3452
2021
Q2 		$22K Sell
33
-14
-30% -$8.07K ﹤0.01% 3033
2021
Q1 		$41K Buy
47
+7
+18% +$7.45K ﹤0.01% 2554
2020
Q4 		$37K Hold
40
– – ﹤0.01% 1967
2020
Q3 		$41K Buy
40
+32
+400% +$34.4K ﹤0.01% 1700
2020
Q2 		$8K Buy
+8
New +$7.43K ﹤0.01% 2255
2019
Q4 		– Sell
-80
Closed -$74K – 1272
2019
Q3 		$74K Hold
80
– – ﹤0.01% 870
2019
Q2 		$90K Buy
+80
New +$87.6K ﹤0.01% 790

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

CAPTRUST Financial Advisors's KYNB Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Kyntra Bio (KYNB) in Q1 2024, closing a stake of 618 shares — an estimated $13.7K sold.

CAPTRUST Financial Advisors first reported a position in KYNB in Q2 2019 and held it in 13 quarters. The position peaked at $190K in Q1 2023. 112 funds tracked by Wall St. Rank hold KYNB as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining Kyntra Bio position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 618 Kyntra Bio shares in Q1 2024, an estimated $13.7K.
  • CAPTRUST Financial Advisors first reported a position in Kyntra Bio in Q2 2019 and held it in 13 quarters.
  • CAPTRUST Financial Advisors's Kyntra Bio position peaked at $190K in Q1 2023.
  • 112 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.